Big, Small Plans Split On Medicare Drug Price Negotiation

By John Wilkerson / October 13, 2021 at 2:00 PM
Small insurance companies are more likely than big insurers to support letting Medicare negotiate prices for the most expensive drugs in part because doing so would help smaller insurers compete on premiums with larger insurers, sources familiar with the industry say. They say the split is demonstrated by the difference in positions between AHIP, which is influenced by large insurers and hasn’t taken a position on the policy, and the Alliance of Community Health Plans, which represents nonprofit plans and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.